Pyoderma clinical trials

The registry lists 11 studies for Pyoderma across 6 countries. 2 are recruiting or about to start. 4 of them are mainly about Pyoderma (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-28. Counting its narrower condition Pyoderma Gangrenosum too: 42 studies, 7 open.

Get an email when these change. Save the Pyoderma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 7
Recruiting: 1
Not yet recruiting: 1
Active, not recruiting: 1
Withdrawn: 1

Phase

Phase 2: 3
Phase 4: 1
Early Phase 1: 1
Phase 3: 1

Where

United States: 4
Fiji: 3
Russian Federation: 1
Belarus: 1
Australia: 1
Latvia: 1

Who runs them

Oregon Health and Science University (3) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · Menzies School of Health Research (1) · Valenta Pharm JSC (1) · SWISS BIOPHARMA MED GmbH (1) · U.S. Wound Registry (1) · Merck Sharp & Dohme LLC (1)

What is being tested here

Drugs under test in Pyoderma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Bimekizumab	1	0	1
Guselkumab	0	0	1
Baricitinib	0	0	1
Dioxidine	0	1	1

Coming up

0phase 3 studies under way

1study finishes main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The study

Aug 2027Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG) · Oregon Health and Science University

Who these studies take

Of the 1 Pyoderma studies recruiting now, 1 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (100%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 1
Age	Women	Men
10	1 (100%)	1 (100%)
18	1 (100%)	1 (100%)
30	1 (100%)	1 (100%)
40	1 (100%)	1 (100%)
50	1 (100%)	1 (100%)
65	1 (100%)	1 (100%)
75	1 (100%)	1 (100%)
85	1 (100%)	1 (100%)

Across all 11 studies, recruiting or not: 45% stop at 75 or younger and 45% at 65; 55% take children; 0% are for women only and 0% for men only; 27% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 11 of 11. search them.